difenacoum
Sign in to savethumb|right|Professional bitebox containing difenacoum and others. Difenacoum is an anticoagulant of the 4-hydroxycoumarin vitamin K antagonist type. It has anticoagulant effects and is used commercially as a rodenticide. It was first introduced in 1976 and first registered in the USA in 2007.
Research
174 papers- Difenacoum (Neosorexa) poisoning.British medical journal (Clinical research ed.) · 1982
- Covert poisoning with difenacoum: diagnosis and follow-up difficulties.Clinical chemistry and laboratory medicine · 2022
- Anticoagulant rodenticides.Toxicological reviews · 2005
- Elevated difenacoum metabolism is involved in the difenacoum-resistant phenotype observed in Berkshire rats homozygous for the L120Q mutation in the vitamin K epoxide reductase complex subunit 1 (Vkorc1) gene.Pest management science · 2018
- Importance of segmental hair analysis in a suspected case of attempted homicide by flocoumafen and difenacoum.Forensic science international · 2020
via PubMed
Article
5 sectionsContents
- Formulation
- Uses
- Safety treatment and toxicity
- See also
- References
thumb|right|Professional bitebox containing difenacoum and others. Difenacoum is an anticoagulant of the 4-hydroxycoumarin vitamin K antagonist type. It has anticoagulant effects and is used commercially as a rodenticide. It was first introduced in 1976 and first registered in the USA in 2007.
==Formulation== Difenacoum is sold as blue-green and red pellets.